Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Zohar

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Statistics in Medicine|May 5, 2026
Innovative Clinical Trial Approach for Evaluating Digital Medical Devices Under European Fast-Track Regulatory FrameworksMoreno Ursino, Sandrine Boulet, Corinne Collignon, et al.
Statistical Methods in Medical Research|April 10, 2019
Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer dataSandrine Boulet, Moreno Ursino, Peter Thall, et al.
British Journal of Haematology|November 20, 2002
Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II studyDominique Farge, Jean Pierre Marolleau, Sarah Zohar, et al.
Melanoma Research|October 28, 2009
Interest in an original methodology to define the optimal dosage of interferon-alpha-2a in metastatic melanoma patientsSarah Zohar, Jacques Medioni, Céleste Lebbé, et al.
Transfusion|September 21, 2007
Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresisFrançois Lefrère, Sarah Zohar, Sandrine Beaudier, et al.
Haematologica|April 6, 2006
A double-blind low dose-finding phase II study of granulocyte colony-stimulating factor combined with chemotherapy for stem cell mobilization in patients with non-Hodgkin's lymphomaFrançois Lefrère, Sarah Zohar, Jean-Louis Bresson, et al.
Therapie|October 11, 2025
Digital pharmacological twins: Bridging multi-scale modelling and artificial intelligence for precision medicine: The DIGPHAT consortiumJean-Baptiste Woillard, Sébastien Benzekry, Julie Josse, et al.
Pharmaceutics|April 30, 2021
The Use of Translational Modelling and Simulation to Develop Immunomodulatory Therapy as an Adjunct to Antibiotic Treatment in the Context of PneumoniaRobin Michelet, Moreno Ursino, Sandrine Boulet, et al.
Neuro-Oncology|January 31, 2006
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastomaAlexandre Carpentier, Florence Laigle-Donadey, Sarah Zohar, et al.
Neuro-Oncology|March 24, 2010
Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II studyAlexandre Carpentier, Philippe Metellus, Renata Ursu, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Statistics in Medicine|May 5, 2026
Innovative Clinical Trial Approach for Evaluating Digital Medical Devices Under European Fast-Track Regulatory FrameworksMoreno Ursino, Sandrine Boulet, Corinne Collignon, et al.
Statistical Methods in Medical Research|April 10, 2019
Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer dataSandrine Boulet, Moreno Ursino, Peter Thall, et al.
British Journal of Haematology|November 20, 2002
Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II studyDominique Farge, Jean Pierre Marolleau, Sarah Zohar, et al.
Melanoma Research|October 28, 2009
Interest in an original methodology to define the optimal dosage of interferon-alpha-2a in metastatic melanoma patientsSarah Zohar, Jacques Medioni, Céleste Lebbé, et al.
Transfusion|September 21, 2007
Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresisFrançois Lefrère, Sarah Zohar, Sandrine Beaudier, et al.
Haematologica|April 6, 2006
A double-blind low dose-finding phase II study of granulocyte colony-stimulating factor combined with chemotherapy for stem cell mobilization in patients with non-Hodgkin's lymphomaFrançois Lefrère, Sarah Zohar, Jean-Louis Bresson, et al.
Therapie|October 11, 2025
Digital pharmacological twins: Bridging multi-scale modelling and artificial intelligence for precision medicine: The DIGPHAT consortiumJean-Baptiste Woillard, Sébastien Benzekry, Julie Josse, et al.
Pharmaceutics|April 30, 2021
The Use of Translational Modelling and Simulation to Develop Immunomodulatory Therapy as an Adjunct to Antibiotic Treatment in the Context of PneumoniaRobin Michelet, Moreno Ursino, Sandrine Boulet, et al.
Neuro-Oncology|January 31, 2006
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastomaAlexandre Carpentier, Florence Laigle-Donadey, Sarah Zohar, et al.
Neuro-Oncology|March 24, 2010
Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II studyAlexandre Carpentier, Philippe Metellus, Renata Ursu, et al.
Pageof 9